Juliana Suso Jaramillo
Corporate Officer/Principal chez INTERCONEXIÓN ELÉCTRICA S.A. E.S.P.
Profil
Juliana Suso Jaramillo is currently the Chief Institutional Relations Officer at Interconexion Eléctrica SA ESP.
Previously, she worked as a Business Manager at Wyeth, Inc. and as a General Manager at Tour Vacation Hoteles Azul SAS from 2011 to 2013.
She also served as a Manager-New Products at Bayer SA (Colombia).
Ms. Suso Jaramillo obtained her undergraduate degree from The Methodist University, Inc.
Postes actifs de Juliana Suso Jaramillo
| Sociétés | Poste | Début |
|---|---|---|
| INTERCONEXIÓN ELÉCTRICA S.A. E.S.P. | Corporate Officer/Principal | 28/09/2020 |
Anciens postes connus de Juliana Suso Jaramillo
| Sociétés | Poste | Fin |
|---|---|---|
Wyeth, Inc. /Biopharmaceutical Manufacturing Operations/
 Wyeth, Inc. /Biopharmaceutical Manufacturing Operations/ BiotechnologyHealth Technology Part of Johnson & Johnson, Wyeth, Inc. /Biopharmaceutical Manufacturing Operations/ is a private company that manufactures biopharmaceutical products. The company is based in New York, NY. Wyeth, Inc. /Biopharmaceutical Manufacturing Operations was acquired by Centocor, Inc. from Wyeth LLC on April 06, 2004. | Corporate Officer/Principal | - |
| Bayer SA (Colombia) | Corporate Officer/Principal | - |
Formation de Juliana Suso Jaramillo
| The Methodist University, Inc. | Undergraduate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| INTERCONEXIÓN ELÉCTRICA S.A. E.S.P. | Utilities |
| Entreprise privées | 2 |
|---|---|
Wyeth, Inc. /Biopharmaceutical Manufacturing Operations/
Wyeth, Inc. /Biopharmaceutical Manufacturing Operations/ BiotechnologyHealth Technology Part of Johnson & Johnson, Wyeth, Inc. /Biopharmaceutical Manufacturing Operations/ is a private company that manufactures biopharmaceutical products. The company is based in New York, NY. Wyeth, Inc. /Biopharmaceutical Manufacturing Operations was acquired by Centocor, Inc. from Wyeth LLC on April 06, 2004. | Health Technology |
| Bayer SA (Colombia) |
